Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer-A Done Deal?

被引：7
|
作者：
Gulstene, S. [1 ]
Ruwanpura, T. [2 ]
Palma, D. [1 ]
Joseph, N. [3 ]
机构：
[1] London Hlth Sci Ctr, Dept Radiat Oncol, London, ON, Canada
[2] Christie NHS Fdn Trust, Manchester, England
[3] Minist Hlth, Colombo, Sri Lanka
来源：
CLINICAL ONCOLOGY | 2022年 / 34卷 / 11期
关键词：
Early -stage lung cancer; lung cancer; non -small cell lung cancer; NSCLC; SABR; SBRT; BODY RADIATION-THERAPY; TUMORS; SABR; PNEUMONITIS; DISEASE; SBRT; VALIDATION; RECURRENCE; PREDICTION; EXPERIENCE;
D O I：
10.1016/j.clon.2022.08.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Stereotactic ablative radiotherapy (SABR) is an important curative-intent treatment option for early-stage non-small cell lung cancer. It offers good cancer control without invasive surgery and has become the standard of care for medically inoperable patients. The literature on SABR for early-stage non-small cell lung cancer is substantial and continues to grow. However, there remain areas of controversy where data are limited -notably the use of SABR in medically operable patients. Other areas of some debate include the treatment of central/ultra-central and large (>5 cm) lesions, as well as treatment with co-existing interstitial lung disease. This review article provides an overview of the current literature together with a discussion of future directions.(c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：733 / 740
页数：8
相关论文
共 50 条
  • [41] Prognostic factors for control of early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Charlton, Thomas
    Hindocha, Sumeet
    Hanumanthappa, Nikesh
    Smith, Daniel
    Vivekanandan, Sindu
    Taylor, Benjamin
    Skwarski, Michael
    Ahmad, Shahreen
    LUNG CANCER, 2021, 156 : S60 - S61
  • [42] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
  • [43] Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer
    Say, C.
    Diehn, M.
    Loo, B. W., Jr.
    Shultz, D. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E437 - E437
  • [44] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [45] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
  • [46] Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
    Elbanna, May
    Shiue, Kevin
    Edwards, Donna
    Cerra-Franco, Alberto
    Agrawal, Namita
    Hinton, Jason
    Mereniuk, Todd
    Huang, Christina
    Ryan, Joshua L.
    Smith, Jessica
    Aaron, Vasantha D.
    Burney, Heather
    Zang, Yong
    Holmes, Jordan
    Langer, Mark
    Zellars, Richard
    Lautenschlaeger, Tim
    CLINICAL LUNG CANCER, 2021, 22 (03) : E342 - E359
  • [47] Repeat Stereotactic Ablative Radiotherapy for Isolated Local Recurrence of Early-Stage NSCLC
    De, B.
    Zhang, X.
    Brooks, E. D.
    Kang, J.
    Verma, V.
    Chang, J. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E139 - E140
  • [48] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Jacobs, Corbin D.
    Mehta, Kurren
    Gao, Junheng
    Wang, Xiaofei
    Salama, Joseph K.
    Kelsey, Chris R.
    Torok, Jordan A.
    CLINICAL LUNG CANCER, 2022, 23 (02) : 177 - 184
  • [49] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [50] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
12345